1. Home
  2. REFR vs VNRX Comparison

REFR vs VNRX Comparison

Compare REFR & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Research Frontiers Incorporated

REFR

Research Frontiers Incorporated

N/A

Current Price

$0.45

Market Cap

21.6M

Sector

Miscellaneous

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.42

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REFR
VNRX
Founded
1965
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.6M
24.5M
IPO Year
1995
2012

Fundamental Metrics

Financial Performance
Metric
REFR
VNRX
Price
$0.45
$0.42
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$1.67
AVG Volume (30 Days)
82.3K
631.9K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
$1,488,642.00
$1,727,384.00
Revenue This Year
N/A
$355.66
Revenue Next Year
N/A
$849.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40.04
52 Week Low
$0.35
$0.13
52 Week High
$2.70
$3.26

Technical Indicators

Market Signals
Indicator
REFR
VNRX
Relative Strength Index (RSI) 41.39 19.26
Support Level $0.35 $0.18
Resistance Level $0.52 $0.91
Average True Range (ATR) 0.04 0.08
MACD 0.00 -0.01
Stochastic Oscillator 37.56 0.02

Price Performance

Historical Comparison
REFR
VNRX

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

Share on Social Networks: